Zobrazeno 1 - 10
of 100
pro vyhledávání: '"Roland Schott"'
Autor:
Simon Nannini, Florian Guisier, Hubert Curcio, Charles Ricordel, Pierre Demontrond, Safa Abdallahoui, Seyyid Baloglu, Laurent Greillier, Christos Chouaid, Roland Schott
Publikováno v:
Current Oncology, Vol 31, Iss 3, Pp 1656-1666 (2024)
Non-small cell lung cancer (NSCLC) is the most common cause of brain metastasis (BM). Little is known about immune checkpoint inhibitor activity in the central nervous system, especially in patients receiving monotherapy for tumors with a tumor propo
Externí odkaz:
https://doaj.org/article/12578945492840c0b16d19f635987c77
Autor:
Joris Mallard, Elyse Hucteau, Laura Bender, Fabien Moinard‐Butot, Emma Rochelle, Lauréline Boutonnet, Antoine Grandperrin, Roland Schott, Carole Pflumio, Philippe Trensz, Michal Kalish‐Weindling, Anne‐Laure Charles, Bernard Gény, Fabrice Favret, Xavier Pivot, Thomas J. Hureau, Allan F. Pagano
Publikováno v:
Journal of Cachexia, Sarcopenia and Muscle, Vol 15, Iss 1, Pp 292-305 (2024)
Abstract Background Breast cancer patients are commonly treated with sequential administrations of epirubicin–cyclophosphamide (EC) and paclitaxel (TAX). The chronic effect of this treatment induces skeletal muscle alterations, but the specific eff
Externí odkaz:
https://doaj.org/article/389b65d381654c5b9b5742b279c46341
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
Non-small cell lung cancer (NSCLC) is the most prevalent form of lung cancer, accounting for approximately 85% of cases of lung cancer. The standard first-line therapy for patients without oncogenic driver metastatic NSCLC is anti PD-L1 immune checkp
Externí odkaz:
https://doaj.org/article/02beef5567b249f3bd01902bdb19fc10
Publikováno v:
Journal of Medical Case Reports, Vol 17, Iss 1, Pp 1-4 (2023)
Abstract Background Acrometastasis is an uncommon finding in non-small cell lung cancer and is usually a sign of multimetastatic disease. Few case reports have suggested solitary digital metastasis as the single secondary lesion of oligometastatic no
Externí odkaz:
https://doaj.org/article/2bc6a3c8f52341c094d558f6737ca2e0
Autor:
Yaniss Belaroussi, Fanny Bouteiller, Carine Bellera, David Pasquier, Maurice Perol, Didier Debieuvre, Thomas Filleron, Nicolas Girard, Roland Schott, Simone Mathoulin-Pélissier, Anne-Laure Martin, Sophie Cousin
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-11 (2023)
Abstract Treatment of metastatic non-small cell lung cancer (mNSCLC) has been modified due to the development of immunotherapy. We assessed survival outcomes (overall [OS] and progression-free [rwPFS] survivals, time-to-next-treatment [TNT]) in mNSCL
Externí odkaz:
https://doaj.org/article/d9b0e457e3b6460188e6d1f1e06df03b
Autor:
Clara Le Fèvre, Roger Sun, Hélène Cebula, Alicia Thiery, Delphine Antoni, Roland Schott, François Proust, Jean-Marc Constans, Georges Noël
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-9 (2022)
Abstract In glioblastoma, the response to treatment assessment is essentially based on the 2D tumor size evolution but remains disputable. Volumetric approaches were evaluated for a more accurate estimation of tumor size. This study included 57 patie
Externí odkaz:
https://doaj.org/article/91343b538374454d981e843ef2cf4723
Autor:
Joris Mallard, Elyse Hucteau, Anne‐Laure Charles, Laura Bender, Claire Baeza, Mathilde Pélissie, Philippe Trensz, Carole Pflumio, Michal Kalish‐Weindling, Bernard Gény, Roland Schott, Fabrice Favret, Xavier Pivot, Thomas J. Hureau, Allan F. Pagano
Publikováno v:
Journal of Cachexia, Sarcopenia and Muscle, Vol 13, Iss 3, Pp 1896-1907 (2022)
Abstract Background Chemotherapy is extensively used to treat breast cancer and is associated with skeletal muscle deconditioning, which is known to reduce patients' quality of life, treatment efficiency, and overall survival. To date, skeletal muscl
Externí odkaz:
https://doaj.org/article/153e49271b05443db30ffdc4ebbb2f8c
Autor:
Fabien Moinard-Butot, Simon Nannini, Cathie Fischbach, Safa Abdallahoui, Martin Demarchi, Thierry Petit, Laura Bender, Roland Schott
Publikováno v:
Cancers, Vol 15, Iss 20, p 4940 (2023)
Lung cancers with ALK rearrangement represent less than 5% of all lung cancers. ALK inhibitors are currently used to treat first-line metastatic non-small cell lung cancer with ALK rearrangement. Compared to chemotherapy, ALK inhibitors have improved
Externí odkaz:
https://doaj.org/article/d7ca1d92963e4b76ac142750a69ed4a6
Autor:
Guillaume Virbel, David G. Cox, Anne Olland, Pierre-Emmanuel Falcoz, Clara Le Fevre, Roland Schott, Delphine Antoni, Georges Noel
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
PurposeThe oligometastatic stage is an intermediate stage of cancer between the localized stage and polymetastatic stage. The prognosis of patients in this stage also appears to be intermediate. Lung stereotactic body radiotherapy is a possible tool
Externí odkaz:
https://doaj.org/article/fe42c2b1dabe4a86a16dbe53ea2d5494
Autor:
Lucas Geyer, Thibaut Wolf, Marie-Pierre Chenard, Helene Cebula, Roland Schott, Georges Noel, Eric Guerin, Erwan Pencreach, Damien Reita, Natacha Entz-Werlé, Benoît Lhermitte
Publikováno v:
Cancers, Vol 15, Iss 5, p 1512 (2023)
CDKN2A is a tumor suppressor gene encoding the p16 protein, a key regulator of the cell cycle. CDKN2A homozygous deletion is a central prognostic factor for numerous tumors and can be detected by several techniques. This study aims to evaluate the ex
Externí odkaz:
https://doaj.org/article/607db1c665dd402b90bde3b5ca658f13